Masimo receives offer of up to $950 mln for consumer business
Adds background in paragraph 5, analyst comments in paragraphs 6-7
By Christy Santhosh
July 8 (Reuters) -Masimo MASI.O said on Monday a potential joint venture partner is prepared to offer $850 million to $950 million for its consumer business, which includes health and audio products.
Masimo and the potential partner, which it did not name, are in active discussions regarding the terms of the joint venture, where the medical device maker has proposed to handle the process and outcome of its ongoing litigation with Apple AAPL.O.
The company is engaged in a legal battle with Apple over a patent dispute on the blood oxygen sensors in newer Apple Watch models, forcing the iPhone maker to sell the devices without the feature.
Masimo intends to negotiate for a higher price for its consumer business, which includes health tracking watches and audio devices such as speakers and headphones. It will also continue to consider a possible spinoff of the business into a new public company.
The company had acquired consumer audio products maker Sound United in 2022 for about $1 billion — an acquisition that was poorly received by investors and sent its shares tumbling.
BTIG analyst Marie Thibault said the proposed offer was lower than the Sound United deal, albeit higher than what the brokerage expected.
"The cash deal would be enough to defray much of (Masimo's) $876 million debt obligations," Thibault wrote in a note.
Masimo is locked in a proxy contest with activist investor Politan Capital Management, which has long criticized the California-based company's board oversight and expressed concerns about its purchase of Sound United.
Quentin Koffey-owned Politan, which owns nearly a 9% stake in Masimo, has been seeking to get its own candidates elected on the company's board.
Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
